D66E (p.Asp66Glu) variant of NPHS2 (Podocin)

D66E (p.Asp66Glu) in NPHS2 (Podocin) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.29 / 1. The record also includes population frequency data and structural context.

D66E (p.Asp66Glu) variant details